ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dexlansoprazole Delayed-Release Capsules Market Research Report 2025
Published Date: 2025-02-13
|
Report Code: QYRE-Auto-34X18652
Home | Market Reports
Global Dexlansoprazole Delayed Release Capsules Market Research Report 2025
BUY CHAPTERS

Global Dexlansoprazole Delayed-Release Capsules Market Research Report 2025

Code: QYRE-Auto-34X18652
Report
2025-02-13
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda Pharmaceuticals
Endo
TWi Pharmaceuticals
Viatris

Dexlansoprazole Delayed-Release Capsules Market Size

The global market for Dexlansoprazole Delayed-Release Capsules was valued at US$ 685 million in the year 2024 and is projected to reach a revised size of US$ 916 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Dexlansoprazole Delayed-Release Capsules Market

Dexlansoprazole Delayed-Release Capsules Market

Dexlansoprazole comes only in the form of a delayed-release capsule you take by mouth. Delayed-release means the drug is released into your body more slowly. Dexlansoprazole oral capsule is used to reduce the amount of acid in your stomach.
North American market for Dexlansoprazole Delayed-Release Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dexlansoprazole Delayed-Release Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dexlansoprazole Delayed-Release Capsules include Takeda Pharmaceuticals, Endo, TWi Pharmaceuticals, Viatris, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dexlansoprazole Delayed-Release Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexlansoprazole Delayed-Release Capsules.
The Dexlansoprazole Delayed-Release Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dexlansoprazole Delayed-Release Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dexlansoprazole Delayed-Release Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dexlansoprazole Delayed-Release Capsules Market Report

Report Metric Details
Report Name Dexlansoprazole Delayed-Release Capsules Market
Accounted market size in year US$ 685 million
Forecasted market size in 2031 US$ 916 million
CAGR 4.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 30mg
  • 60mg
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceuticals, Endo, TWi Pharmaceuticals, Viatris
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dexlansoprazole Delayed-Release Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dexlansoprazole Delayed-Release Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Dexlansoprazole Delayed-Release Capsules Market growing?

Ans: The Dexlansoprazole Delayed-Release Capsules Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Dexlansoprazole Delayed-Release Capsules Market size in 2031?

Ans: The Dexlansoprazole Delayed-Release Capsules Market size in 2031 will be US$ 916 million.

Who are the main players in the Dexlansoprazole Delayed-Release Capsules Market report?

Ans: The main players in the Dexlansoprazole Delayed-Release Capsules Market are Takeda Pharmaceuticals, Endo, TWi Pharmaceuticals, Viatris

What are the Application segmentation covered in the Dexlansoprazole Delayed-Release Capsules Market report?

Ans: The Applications covered in the Dexlansoprazole Delayed-Release Capsules Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Dexlansoprazole Delayed-Release Capsules Market report?

Ans: The Types covered in the Dexlansoprazole Delayed-Release Capsules Market report are 30mg, 60mg

1 Dexlansoprazole Delayed-Release Capsules Market Overview
1.1 Product Definition
1.2 Dexlansoprazole Delayed-Release Capsules by Type
1.2.1 Global Dexlansoprazole Delayed-Release Capsules Market Value Comparison by Type (2024 VS 2031)
1.2.2 30mg
1.2.3 60mg
1.3 Dexlansoprazole Delayed-Release Capsules by Application
1.3.1 Global Dexlansoprazole Delayed-Release Capsules Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dexlansoprazole Delayed-Release Capsules Market Size Estimates and Forecasts
1.4.1 Global Dexlansoprazole Delayed-Release Capsules Revenue 2020-2031
1.4.2 Global Dexlansoprazole Delayed-Release Capsules Sales 2020-2031
1.4.3 Global Dexlansoprazole Delayed-Release Capsules Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dexlansoprazole Delayed-Release Capsules Market Competition by Manufacturers
2.1 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dexlansoprazole Delayed-Release Capsules Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dexlansoprazole Delayed-Release Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dexlansoprazole Delayed-Release Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dexlansoprazole Delayed-Release Capsules, Product Type & Application
2.7 Global Key Manufacturers of Dexlansoprazole Delayed-Release Capsules, Date of Enter into This Industry
2.8 Global Dexlansoprazole Delayed-Release Capsules Market Competitive Situation and Trends
2.8.1 Global Dexlansoprazole Delayed-Release Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dexlansoprazole Delayed-Release Capsules Players Market Share by Revenue
2.8.3 Global Dexlansoprazole Delayed-Release Capsules Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dexlansoprazole Delayed-Release Capsules Market Scenario by Region
3.1 Global Dexlansoprazole Delayed-Release Capsules Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Region: 2020-2031
3.2.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Region: 2020-2025
3.2.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Region: 2026-2031
3.3 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region: 2020-2031
3.3.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region: 2020-2025
3.3.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region: 2026-2031
3.4 North America Dexlansoprazole Delayed-Release Capsules Market Facts & Figures by Country
3.4.1 North America Dexlansoprazole Delayed-Release Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2020-2031)
3.4.3 North America Dexlansoprazole Delayed-Release Capsules Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dexlansoprazole Delayed-Release Capsules Market Facts & Figures by Country
3.5.1 Europe Dexlansoprazole Delayed-Release Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2020-2031)
3.5.3 Europe Dexlansoprazole Delayed-Release Capsules Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dexlansoprazole Delayed-Release Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Dexlansoprazole Delayed-Release Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales by Region (2020-2031)
3.6.3 Asia Pacific Dexlansoprazole Delayed-Release Capsules Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dexlansoprazole Delayed-Release Capsules Market Facts & Figures by Country
3.7.1 Latin America Dexlansoprazole Delayed-Release Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dexlansoprazole Delayed-Release Capsules Sales by Country (2020-2031)
3.7.3 Latin America Dexlansoprazole Delayed-Release Capsules Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dexlansoprazole Delayed-Release Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Dexlansoprazole Delayed-Release Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2020-2031)
4.1.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2020-2025)
4.1.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2026-2031)
4.1.3 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2020-2031)
4.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2020-2031)
4.2.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2020-2025)
4.2.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2026-2031)
4.2.3 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2020-2031)
4.3 Global Dexlansoprazole Delayed-Release Capsules Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2020-2031)
5.1.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2020-2025)
5.1.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2026-2031)
5.1.3 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2020-2031)
5.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2020-2031)
5.2.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2020-2025)
5.2.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2026-2031)
5.2.3 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2020-2031)
5.3 Global Dexlansoprazole Delayed-Release Capsules Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda Pharmaceuticals
6.1.1 Takeda Pharmaceuticals Company Information
6.1.2 Takeda Pharmaceuticals Description and Business Overview
6.1.3 Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio
6.1.5 Takeda Pharmaceuticals Recent Developments/Updates
6.2 Endo
6.2.1 Endo Company Information
6.2.2 Endo Description and Business Overview
6.2.3 Endo Dexlansoprazole Delayed-Release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Endo Dexlansoprazole Delayed-Release Capsules Product Portfolio
6.2.5 Endo Recent Developments/Updates
6.3 TWi Pharmaceuticals
6.3.1 TWi Pharmaceuticals Company Information
6.3.2 TWi Pharmaceuticals Description and Business Overview
6.3.3 TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio
6.3.5 TWi Pharmaceuticals Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Dexlansoprazole Delayed-Release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Dexlansoprazole Delayed-Release Capsules Product Portfolio
6.4.5 Viatris Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dexlansoprazole Delayed-Release Capsules Industry Chain Analysis
7.2 Dexlansoprazole Delayed-Release Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dexlansoprazole Delayed-Release Capsules Production Mode & Process Analysis
7.4 Dexlansoprazole Delayed-Release Capsules Sales and Marketing
7.4.1 Dexlansoprazole Delayed-Release Capsules Sales Channels
7.4.2 Dexlansoprazole Delayed-Release Capsules Distributors
7.5 Dexlansoprazole Delayed-Release Capsules Customer Analysis
8 Dexlansoprazole Delayed-Release Capsules Market Dynamics
8.1 Dexlansoprazole Delayed-Release Capsules Industry Trends
8.2 Dexlansoprazole Delayed-Release Capsules Market Drivers
8.3 Dexlansoprazole Delayed-Release Capsules Market Challenges
8.4 Dexlansoprazole Delayed-Release Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Takeda Pharmaceuticals
Endo
TWi Pharmaceuticals
Viatris
List of Tables
 Table 1. Global Dexlansoprazole Delayed-Release Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dexlansoprazole Delayed-Release Capsules Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dexlansoprazole Delayed-Release Capsules Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dexlansoprazole Delayed-Release Capsules Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dexlansoprazole Delayed-Release Capsules Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dexlansoprazole Delayed-Release Capsules Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dexlansoprazole Delayed-Release Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dexlansoprazole Delayed-Release Capsules, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dexlansoprazole Delayed-Release Capsules, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dexlansoprazole Delayed-Release Capsules, Product Type & Application
 Table 12. Global Key Manufacturers of Dexlansoprazole Delayed-Release Capsules, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dexlansoprazole Delayed-Release Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dexlansoprazole Delayed-Release Capsules as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dexlansoprazole Delayed-Release Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Region (2020-2025)
 Table 19. Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Region (2026-2031)
 Table 21. Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2020-2025)
 Table 23. Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2026-2031)
 Table 25. North America Dexlansoprazole Delayed-Release Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dexlansoprazole Delayed-Release Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dexlansoprazole Delayed-Release Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dexlansoprazole Delayed-Release Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dexlansoprazole Delayed-Release Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dexlansoprazole Delayed-Release Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dexlansoprazole Delayed-Release Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dexlansoprazole Delayed-Release Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dexlansoprazole Delayed-Release Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dexlansoprazole Delayed-Release Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dexlansoprazole Delayed-Release Capsules Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dexlansoprazole Delayed-Release Capsules Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dexlansoprazole Delayed-Release Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dexlansoprazole Delayed-Release Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dexlansoprazole Delayed-Release Capsules Sales (K Units) by Type (2020-2025)
 Table 51. Global Dexlansoprazole Delayed-Release Capsules Sales (K Units) by Type (2026-2031)
 Table 52. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2020-2025)
 Table 53. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2026-2031)
 Table 54. Global Dexlansoprazole Delayed-Release Capsules Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dexlansoprazole Delayed-Release Capsules Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2020-2025)
 Table 57. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2026-2031)
 Table 58. Global Dexlansoprazole Delayed-Release Capsules Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dexlansoprazole Delayed-Release Capsules Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dexlansoprazole Delayed-Release Capsules Sales (K Units) by Application (2020-2025)
 Table 61. Global Dexlansoprazole Delayed-Release Capsules Sales (K Units) by Application (2026-2031)
 Table 62. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2020-2025)
 Table 63. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2026-2031)
 Table 64. Global Dexlansoprazole Delayed-Release Capsules Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dexlansoprazole Delayed-Release Capsules Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2020-2025)
 Table 67. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2026-2031)
 Table 68. Global Dexlansoprazole Delayed-Release Capsules Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dexlansoprazole Delayed-Release Capsules Price (US$/Unit) by Application (2026-2031)
 Table 70. Takeda Pharmaceuticals Company Information
 Table 71. Takeda Pharmaceuticals Description and Business Overview
 Table 72. Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product
 Table 74. Takeda Pharmaceuticals Recent Developments/Updates
 Table 75. Endo Company Information
 Table 76. Endo Description and Business Overview
 Table 77. Endo Dexlansoprazole Delayed-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Endo Dexlansoprazole Delayed-Release Capsules Product
 Table 79. Endo Recent Developments/Updates
 Table 80. TWi Pharmaceuticals Company Information
 Table 81. TWi Pharmaceuticals Description and Business Overview
 Table 82. TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product
 Table 84. TWi Pharmaceuticals Recent Developments/Updates
 Table 85. Viatris Company Information
 Table 86. Viatris Description and Business Overview
 Table 87. Viatris Dexlansoprazole Delayed-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Viatris Dexlansoprazole Delayed-Release Capsules Product
 Table 89. Viatris Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Dexlansoprazole Delayed-Release Capsules Distributors List
 Table 93. Dexlansoprazole Delayed-Release Capsules Customers List
 Table 94. Dexlansoprazole Delayed-Release Capsules Market Trends
 Table 95. Dexlansoprazole Delayed-Release Capsules Market Drivers
 Table 96. Dexlansoprazole Delayed-Release Capsules Market Challenges
 Table 97. Dexlansoprazole Delayed-Release Capsules Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dexlansoprazole Delayed-Release Capsules
 Figure 2. Global Dexlansoprazole Delayed-Release Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dexlansoprazole Delayed-Release Capsules Market Share by Type: 2024 & 2031
 Figure 4. 30mg Product Picture
 Figure 5. 60mg Product Picture
 Figure 6. Global Dexlansoprazole Delayed-Release Capsules Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Dexlansoprazole Delayed-Release Capsules Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Dexlansoprazole Delayed-Release Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Dexlansoprazole Delayed-Release Capsules Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Dexlansoprazole Delayed-Release Capsules Sales (2020-2031) & (K Units)
 Figure 14. Global Dexlansoprazole Delayed-Release Capsules Average Price (US$/Unit) & (2020-2031)
 Figure 15. Dexlansoprazole Delayed-Release Capsules Report Years Considered
 Figure 16. Dexlansoprazole Delayed-Release Capsules Sales Share by Manufacturers in 2024
 Figure 17. Global Dexlansoprazole Delayed-Release Capsules Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Dexlansoprazole Delayed-Release Capsules Players: Market Share by Revenue in Dexlansoprazole Delayed-Release Capsules in 2024
 Figure 19. Dexlansoprazole Delayed-Release Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Dexlansoprazole Delayed-Release Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Dexlansoprazole Delayed-Release Capsules Sales Market Share by Country (2020-2031)
 Figure 22. North America Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Country (2020-2031)
 Figure 23. United States Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Dexlansoprazole Delayed-Release Capsules Sales Market Share by Country (2020-2031)
 Figure 26. Europe Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2020-2031)
 Figure 34. China Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Dexlansoprazole Delayed-Release Capsules Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Dexlansoprazole Delayed-Release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Dexlansoprazole Delayed-Release Capsules by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Dexlansoprazole Delayed-Release Capsules by Type (2020-2031)
 Figure 54. Global Dexlansoprazole Delayed-Release Capsules Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Dexlansoprazole Delayed-Release Capsules by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Dexlansoprazole Delayed-Release Capsules by Application (2020-2031)
 Figure 57. Global Dexlansoprazole Delayed-Release Capsules Price (US$/Unit) by Application (2020-2031)
 Figure 58. Dexlansoprazole Delayed-Release Capsules Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions